Literature DB >> 8560284

Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.

C A Kattamis1, A C Kattamis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8560284

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  7 in total

1.  Pulmonary function tests in beta thalassemia.

Authors:  M Arora; J Chandra; J C Suri; S Narayan; A K Dutta
Journal:  Indian J Pediatr       Date:  2001-03       Impact factor: 1.967

Review 2.  Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases.

Authors:  J A Barman Balfour; R H Foster
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

3.  HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinicohematological correlation.

Authors:  Rachna Khera; Tejinder Singh; Nita Khuana; Naresh Gupta; A P Dubey
Journal:  Indian J Hematol Blood Transfus       Date:  2014-06-05       Impact factor: 0.900

4.  Accuracy of Reverse Dot-Blot PCR in Detection of Different β-Globin Gene Mutations.

Authors:  N El-Fadaly; A Abd-Elhameed; E Abd-Elbar; M El-Shanshory
Journal:  Indian J Hematol Blood Transfus       Date:  2015-05-27       Impact factor: 0.900

5.  Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test.

Authors:  Holger Cario; Reinhard W Holl; Klaus-Michael Debatin; Elisabeth Kohne
Journal:  Eur J Pediatr       Date:  2003-01-15       Impact factor: 3.183

6.  Thalassaemia and aberrations of growth and puberty.

Authors:  Andreas Kyriakou; Nicos Skordis
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-07-27       Impact factor: 2.576

7.  Therapeutic value of combined therapy with deferasirox and silymarin on iron overload in children with Beta thalassemia.

Authors:  Adel A Hagag; Mohamed S Elfrargy; Rana A Gazar; Aml Ezzat Abd El-Lateef
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.